Atrial fibrillation （AF） is associated with a five-fold increased risk of ischaemic stroke, stroke recurrence and mortality. Anticoagulant therapy may reduce the risk of recurrent stroke by approximately 60% and is ...Atrial fibrillation （AF） is associated with a five-fold increased risk of ischaemic stroke, stroke recurrence and mortality. Anticoagulant therapy may reduce the risk of recurrent stroke by approximately 60% and is more efficacious than anti-platelet agents.展开更多
文摘Atrial fibrillation （AF） is associated with a five-fold increased risk of ischaemic stroke, stroke recurrence and mortality. Anticoagulant therapy may reduce the risk of recurrent stroke by approximately 60% and is more efficacious than anti-platelet agents.
